Bionano Genomics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price RuleGlobeNewsWire • 12/30/20
Bionano Customer Praxis Genomics Accredited by College of American Pathologists, Completing First LDT in US for Constitutional Genetic Disorders that Uses Whole Genome Analysis with Saphyr as Alternative to Chromosomal Microarray and KaryotypingGlobeNewsWire • 12/28/20
Publication Reveals in Side-by-Side Comparison that Method Using PacBio Sequencing Detects Only 72% of the Large Structural Variants Detected by Optical Genome Mapping with SaphyrGlobeNewsWire • 12/23/20
Bionano Genomics Users Present the Saphyr System As a Novel Diagnostic Tool for Hematological Malignancies at ASH 2020GlobeNewsWire • 12/03/20
Bionano Genomics and its Users Present the Saphyr System for Optical Genome Mapping and Various Advancements in Clinical Variant Detection at AMP 2020GlobeNewsWire • 11/19/20
Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/12/20
Multi-Center Evaluation of Bionano Optical Genome Mapping by Cytogenetics Thought Leaders in the US Leads to Recommendation for Bionano's Saphyr to Replace Karyotyping as First-Line Test for Detection and Identification of Structural and Copy Number VariaGlobeNewsWire • 11/11/20
Largest Study To-Date Focused on Undiagnosed Genetic Disease Patients Reveals That Bionano's Optical Genome Mapping Technology Can Diagnose Significantly More Patients Than Standard of Care Methods AloneGlobeNewsWire • 11/05/20
Prowess of Bionano Genomics' Saphyr System in Uncovering Novel Genetic Variations That Cause Cancer and Genetic Disease in Full Display at ASHG 2020GlobeNewsWire • 10/27/20
Bionano Genomics' Saphyr System Shown to be Indispensable for the Analysis of Certain Genetic Disease Causing VariantsGlobeNewsWire • 10/15/20
Boston Children’s Hospital Is Using Bionano’s Saphyr To Study Children With Severe COVID-19 DiseaseGlobeNewsWire • 10/05/20
Bionano Genomics Announces Positive Outcome of Its Special Stockholder MeetingGlobeNewsWire • 09/30/20
Bionano Genomics Announces Continued Expansion of Global Business with Adoption of Saphyr for Next-Generation Cytogenomics in Eastern Europe and AustraliaGlobeNewsWire • 09/29/20
German Accreditation of Laboratory Developed Tests on Bionano’s Saphyr System Accelerates Utilization in Clinical DiagnosticsGlobeNewsWire • 09/24/20
Bionano Data Provides Understanding of Repeat Expansion Disorders Causing Muscular Dystrophy and ALSGlobeNewsWire • 09/17/20
Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to EpilepsyGlobeNewsWire • 09/14/20
Vertebrate Genome Project Rules Bionano Optical Mapping Technology As Essential Part of Assembling Reference Quality GenomesGlobeNewsWire • 09/09/20
Independent Proxy Advisory Firm ISS Recommends Bionano Stockholders Vote “FOR” Authorized Shares Increase ProposalGlobeNewsWire • 09/03/20
Bionano Genomics Announces Adjournment of Special Meeting of Stockholders to September 29, 2020GlobeNewsWire • 08/31/20
Bionano Genomics Emphasizes the Importance of Supporting the Proxy Proposal to Increase its Authorized SharesGlobeNewsWire • 08/28/20